Evaluation of sunobinop for next-day residual effects in healthy participants

HIGHLIGHTS

• What: The total study duration was up to approximately 64 days. be administered at bedtime and next-day residual effects have been observed at 10 mg, this study aimed to evaluate the next-day residual effects of sunobinop across a range of doses. intestinal transit were observed at doses substantially higher than required for therapeutic effect. The aim of this study was to assess the next-day residual effects of an evening dose of sunobinop on Frontiers in Pharmacology frontiersin.org 10.3389/fphar.2024.1432902 DSST scores vs. time by treatment. *p and amp;lt;.05 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.